Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: Made by Bayer AG and Onyx Pharmaceuticals Inc, Nexavar is  approved in the United States for kidney and liver cancer. Eight out of the first nine patients who took the drug saw  improvements in their ability to exercise, and six out of nine  had significant improvement in their right ventricular ejection  fraction, which measures the heart’s ability to pump blood to  the lungs. Four patients had decreased pressure in their pulmonary  artery, which supplies blood to the lungs. “What patients are telling us is they are able to do more  in their daily lives,” said Dr. Mardi Gomberg-Maitland of the  University of Chicago, who presented her findings at a meeting  of the American Thoracic Society in Toronto. The original  research on the drug was done at the University. She said the surprising thing is that the drug worked so  quickly. Patients saw benefits in only four months. The study is the first human trial to examine the  sorafenib, or Nexavar, in pulmonary hypertension, a disease in  which blood vessels feeding the lungs narrow, forcing the heart  to work harder. Like cancer, pulmonary hypertension is a disease marked by  abnormal cell growth, which narrows the arteries feeding the  lungs, reducing blood flow and taxing the heart. Sorafenib  appears to interfere with this process. The trial enrolled patients with stable disease who  continued to take their primary medications, which included a  continuous infusion of a drug called prostacyclin and Pfizer  Inc’s Viagra or sildenafil. Both relax blood vessels that feed  the lungs. Gomberg-Maitland said this therapy typically slows  progression of the disease, but does not reverse it. They added sorafenib for 16 weeks, but at a lower dose than  cancer patients use. Most patients in the trial increased their exercise  capacity, as measured by time on a treadmill or a six-minute  walk test. They saw an average 8 percent improvement in their  right ventricular ejection fraction, a measure of the heart’s  pumping power. Side effects included mild hair loss and skin reactions. The study was designed to last only 16 weeks, but all of  the patients continue to take the drug, some now for more than  a year. “What is exciting about this is all of the patients feel  better and nobody wants to come off the medication,”  Gomberg-Maitland said in a telephone interview. The study was intended to test the safety and dosing of the  drug. It was funded by The Doris Duke Foundation and the  University of Chicago. The researchers now plan to study the drug in 40 to 60  patients at different research centers. Claim: Nexavar helped in pulmonary hypertension study.
[A]: The cancer drug Nexavar is showed  promise in a small study of people with pulmonary hypertension,  a debilitating condition marked by high blood pressure in the  arteries that supply the lungs, U.S. researchers said on  Monday.


[Q]: Paragraph: The organization is a national nonprofit that works to improve rural health care. Program director Shelley Stingley tells the Casper Star-Tribune (http://bit.ly/2veibqx ) that more than $10 million of its contributions in Wyoming has gone to better care in cancer treatment centers. That includes putting eight new digital mammography machines in towns like Torrington and Wheatland. Some of the machines were new equipment to a facility, while others replaced a hospital’s aging machine. Additionally, Stingley says the program sought to provide cancer patients with better radiation treatment. New machines were purchased in Cody, Sheridan and Rock Springs. ___ Information from: Casper (Wyo.) Star-Tribune, http://www.trib.com Claim: Nonprofit has given $25M to Wyoming health care.
[A]: The Leona M. and Harry B. Helmsley Charitable Trust has given more than $25 million for mammogram machines and other medical equipment to Wyoming hospitals and clinics since 2010.


[Q]: Paragraph: "There was no discussion of price, but coffee is a widely available beverage with a generally known price range. The story did not provide absolute risk reduction numbers for the benefit that one might hope to gain from drinking coffee. The real take home from the study was that coffee consumption did not appear to be harmful in terms of the risk a person would die. The story did at least mention anxiety and insomnia as two harms that might be associated with coffee consumption.It would have been more informative to provide some insight as to how commonly these symptoms are associated with coffee use as opposed to other causes. The story did not clearly explain that nature of the study reported on or the conclusions which could or could not be drawn from it because of the study design. While readers were provided with numbers of study subjects and the length of time they were followed, both of which are helpful for understanding how to consider the information, when it came to providing information about the results of the study, only a relative risk reduction was mentioned. Further, the ‘news’, i.e. the findings from a recently published study, was muddled with comments from credentialed individuals who provided their opinions on subject matter that was not supported by the study reported on. Although one researcher said, ""If you want the best of both worlds, drink decaf – avoid the caffeine and get the good stuff,"" the published data demonstrated a strong relationship between caffeine intake and the number of cups of coffee consumed. So while this may be his opinion and may even be supported by other research he has knowledge about, it is not consistent with the study reported on. Another expert interviewed for the study mentioned that it says the key to coffee’s health benefits is its antioxidants. Coffee is a complex entity containing hundreds of different components. It is not possible from a study of this kind to make any sort of conclusion about what is responsible for any particular effect observed. No overt disease-mongering. The lead study author was interviewed for this story. In addition, the story contained quotes from two individuals that were not connected with the study but who had some background related to coffee. The story did not contain any information about other means of lowering the risk of premature death or of dying from a heart attack. The availability of coffee is not in question.Â Drinking coffee was appropriately not portrayed as something new or innovative. Does not appear to be derived exclusively from a press release." Claim: Coffee may have perks for longer living
[A]:
"This was a story about a new analysis of data from the Nurses Health Study and the Health Professionals follow-up study that scrutinized coffee consumption and the incidence of death, coronary disease or cancer. The study found that increasing coffee consumption did not result in more death or death from these specific causes. In the cohort of women studied, after adjusting for confounders, especially for smoking, there were fewer deaths due to cardiovascular disease. The effect of coffee in men appeared more neutral.Ã‚Â    Our primary recommendation is that the story should have emphasized that this was an observational study and that there are limits to the conclusions you can draw from such studies. We know, for example, that other factors (including HRT use and sunscreen use) can be associated with decreased risk of heart disease but when tested in trials were not found to lower risk. Coffee likely falls into that category, a sort of ""healthy user"" effect.Ã‚Â We also all journalists to abandon the use of only relative risk figures. This story stated, ""Women who drank two to three cups of coffee a day, for instance, had a 25% lower risk of dying from heart disease than non-drinkers."" That’s relative risk. You should ask, ""25% of what?"" What is the absolute risk reduction figure? How many out of how many to begin with?"